Dyne Therapeutics (NASDAQ:DYN – Free Report) had its target price reduced by HC Wainwright from $55.00 to $46.00 in a research report report published on Friday morning,Benzinga reports.

Shares of NASDAQ:DYN opened at $13.61 on Friday. Dyne Therapeutics has a 52-week low of $12.87 and a 52-week high of $47.45. The business has a fifty day moving average of $16.98 and a two-hundred ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Full enrollment of Registrational Expansion Cohort of ACHIEVE Trial of DYNE-101 in DM1 Planned for Mid-2025 to Support Submission for U.S. Accelerated Approval - - Full Enrollment of ...

Full enrollment of Registrational Expansion Cohort of ACHIEVE Trial of DYNE-101 in DM1 Planned for Mid-2025 to Support Submission for U.S. Accelerated Approval - - Full Enrollment of Registrational ...

Van Dyne and Waupun fire departments all responded to the scene, along with RIT3 search and rescue, the Ripon Police Department, Wisconsin State Patrol and Life Star EMS. The cause of the fire is ...